dalteparin sodium
PolandDrugs containing this active substance
-
The medicine is used in adults for the treatment of acute deep vein thrombosis, unstable coronary artery disease, and to prevent blood clotting during surgical procedures, hemodialysis, or in immobilized persons. In children and adolescents, it is used for the treatment of venous blood clots.
Form: solution for injection
Active substance Dosage dalteparin sodium 5000 IU ATC: B01AB04
Manufacturer: Catalent France Limoges SAS Z.I. Nord Pfizer Manufacturing Belgium NV
-
The medicine is used in adults to treat acute deep vein thrombosis, unstable coronary artery disease, and to reduce the recurrence of thromboembolic disease in patients with cancer. It is also used for antithrombotic prophylaxis during surgical procedures, in immobilized patients, and to prevent blood clotting during dialysis.
Form: solution for injection
Active substance Dosage dalteparin sodium 7 500 IU ATC: B01AB04
Manufacturer: Catalent France Limoges SAS Z.I. Nord Pfizer Manufacturing Belgium NV
-
The medicine is used in adults to treat acute deep vein thrombosis, unstable coronary artery disease, and to prevent blood clotting during surgical procedures, hemodialysis, or in immobilized persons. In children and adolescents, it is used to treat blood clots in the veins.
Form: solution for injection
Active substance Dosage dalteparin sodium 12 500 IU ATC: B01AB04
Manufacturer: Catalent France Limoges SAS Z.I. Nord Pfizer Manufacturing Belgium NV
-
The medicine is used in adults for the treatment of acute deep vein thrombosis, unstable coronary artery disease, and to prevent blood clotting during surgical procedures, hemodialysis, or in individuals immobilized for medical reasons. In children, it is used for the treatment of venous blood clots.
Form: solution for injection
Active substance Dosage dalteparin sodium 18 000 IU ATC: B01AB04
Manufacturer: Catalent France Limoges SAS Z.I. Nord Pfizer Manufacturing Belgium NV
-
The medicine is used in adults to treat acute deep vein thrombosis, unstable coronary artery disease, and to prevent blood clotting during surgical procedures, hemodialysis, or in immobilized patients. In children and adolescents, it is used to treat blood clots in the veins.
Form: solution for injection
Active substance Dosage dalteparin sodium 125.00 mg ATC: B01AB04
Manufacturer: Catalent France Limoges SAS Z.I. Nord Pfizer Manufacturing Belgium NV
-
The medicine is used in adults to treat acute deep vein thrombosis, unstable coronary artery disease, and to reduce the recurrence of venous thromboembolic disease in patients with cancer. It is also used for antithrombotic prophylaxis during surgical procedures, in individuals immobilized for medical reasons, and to prevent blood clotting during dialysis. In children, the medicine is used to treat blood clots in the veins.
Form: solution for injection
Active substance Dosage dalteparin sodium 15 000 IU ATC: B01AB04
Manufacturer: Catalent France Limoges SAS Z.I. Nord Pfizer Manufacturing Belgium NV
-
The medicine is used in adults to treat acute deep vein thrombosis, unstable coronary artery disease, and to prevent blood clotting during surgical procedures, hemodialysis, or in immobilized patients. In children and adolescents, it is used to treat blood clots in the veins.
Form: solution for injection
Active substance Dosage dalteparin sodium 2500 IU anti Xa/1 ml ATC: B01AB04
Manufacturer: Pfizer Manufacturing Belgium NV